INFANTS
Clinical trials for INFANTS explained in plain language.
Never miss a new study
Get alerted when new INFANTS trials appear
Sign up with your email to follow new studies for INFANTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mpox vaccine trial for babies launches in congo: could half a dose be enough?
⭐️ VACCINE ⭐️ OngoingThis study tests the safety and immune response of the MVA-BN mpox vaccine in 344 infants and children aged 4 to 24 months in the Democratic Republic of the Congo. Half the children receive the standard vaccine dose, and the other half receive a half dose. The goal is to find the…
Matched conditions: INFANTS
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 08, 2026 13:17 UTC
-
Real-world check: is eylea safe and effective for premature babies' eyes?
Knowledge-focused OngoingThis study follows 75 Japanese babies with retinopathy of prematurity (ROP) who are already being treated with Eylea. Researchers will collect data from routine doctor visits over 6 months to see how safe the drug is and whether it stops the abnormal blood vessel growth that can …
Matched conditions: INFANTS
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:26 UTC